- Home
- MTEN vs GRCE Comparison
MTEN vs GRCE Comparison
Compare MTEN & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEN
- GRCE
- Stock Information
- Founded
- MTEN 2015
- GRCE 2002
- Country
- MTEN China
- GRCE United States
- Employees
- MTEN N/A
- GRCE N/A
- Industry
- MTEN Building Products
- GRCE
- Sector
- MTEN Industrials
- GRCE
- Exchange
- MTEN Nasdaq
- GRCE NYSE
- Market Cap
- MTEN 36.6M
- GRCE 30.9M
- IPO Year
- MTEN 2024
- GRCE N/A
- Fundamental
- Price
- MTEN $6.25
- GRCE $3.91
- Analyst Decision
- MTEN
- GRCE
- Analyst Count
- MTEN 0
- GRCE 0
- Target Price
- MTEN N/A
- GRCE N/A
- AVG Volume (30 Days)
- MTEN 39.1K
- GRCE 76.1K
- Earning Date
- MTEN 10-18-2024
- GRCE 01-31-2025
- Dividend Yield
- MTEN N/A
- GRCE N/A
- EPS Growth
- MTEN N/A
- GRCE N/A
- EPS
- MTEN 0.13
- GRCE N/A
- Revenue
- MTEN $9,136,855.00
- GRCE N/A
- Revenue This Year
- MTEN N/A
- GRCE N/A
- Revenue Next Year
- MTEN N/A
- GRCE N/A
- P/E Ratio
- MTEN $47.28
- GRCE N/A
- Revenue Growth
- MTEN 18.30
- GRCE N/A
- 52 Week Low
- MTEN $1.81
- GRCE $2.13
- 52 Week High
- MTEN $9.87
- GRCE $4.97
- Technical
- Relative Strength Index (RSI)
- MTEN N/A
- GRCE N/A
- Support Level
- MTEN N/A
- GRCE N/A
- Resistance Level
- MTEN N/A
- GRCE N/A
- Average True Range (ATR)
- MTEN 0.00
- GRCE 0.00
- MACD
- MTEN 0.00
- GRCE 0.00
- Stochastic Oscillator
- MTEN 0.00
- GRCE 0.00
About MTEN Mingteng International Corporation Inc. Ordinary Shares
Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides a wide range of products including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in automobile, construction machinery, and other manufacturing industries.
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.